Dosimetric predictors of treatment-related lymphopenia induced by palliative radiotherapy: Predictive ability of dose-volume parameters based on body surface contour

Abstract

@font-face { font-family: "Arial"; }@font-face { font-family: "ＭＳ 明朝"; }@font-face { font-family: "Cambria Math"; }@font-face { font-family: "@ＭＳ 明朝"; }@font-face { font-family: "MS ??"; }@font-face { font-family: "Calibri"; }@font-face { font-family: "@MS ??"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0mm 0mm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }p.Default, li.Default, div.Default { margin: 0mm 0mm 0.0001pt; font-size: 12pt; font-family: Calibri; color: black; }.MsoChpDefault { font-size: 10pt; }div.WordSection1 { }

Background. Radiation-related lymphopenia has been associated with poor patient outcome. We sought to identify predictors of lymphopenia after palliative radiotherapy, with a focus on dose-volume parameters.

Materials and methods. To retrospectively assess patients with various cancers who had undergone palliative radiotherapy, we delineated three organs at risk: the volume enclosed by the body surface contour (body A), the volume left after excluding air, pleural effusion, ascites, bile, urine, and intestinal content (body B), and the volume of the bone marrow (BM). We then noted the absolute volume of the three organs at risk that had received 5 - 30 Gy, and assessed the predictive value for post-treatment lymphopenia of grade 3 or higher (LP3+).

Results. Of 54 patients, 23 (43%) developed LP3+. Univariate logistic regression analysis showed that body A V5, body A V10, body B V5, body B V10, the number of fractions, and splenic irradiation were significant predictors of LP3+ (p < 0.05). By multivariate analysis, body A V5, body A V10, body B V5, body B V10, and the number of fractions retained significance (p < 0.05). BM dose-volume parameters did not predict lymphopenia.

Conclusions. Higher body A and body B dose-volume parameters and a larger number of fractions may be predictors of severe lymphopenia after palliative radiotherapy.